In a late-stage trial, people who got Revolution Medicines' Rasonque, or daraxonrasib, lived about twice as long as people who got standard care.
Erika Edwards is a reporter and producer at various prominent media outlets. She specializes in health and wellness, covering topics such as public health, oncology, and mental health, while also exploring the intersections of climate change and alternative medicine. Erika's work has been featured in notable platforms including NBC News, Telemundo, and Yahoo News.